About the Journal
Aims and Scope
Gland Surgery (Gland Surg; GS, Print ISSN 2227-684X; Online ISSN 2227-8575), indexed in PubMed/PubMed Central/Scopus/SCIE, is an open access, peer-reviewed journal focusing on recent scientific advances in gland surgery. The latest impact factor (2020 citation year) is 2.953.
As a journal launched in May 2012, GS was a bimonthly publication during 2015 to 2020. To meet the demands of fast-growing submissions, the journal turns into a monthly publication in 2021.
As a monthly published journal, it aims at providing cutting-edge findings and practical information on diagnosis, prevention, and treatment of gland diseases, such as breast, thyroid, adrenal, pancreas surgery and other related fields. Dedicated to the understanding and treatment of gland diseases, this multidisciplinary periodical publishes articles that describe basic, translational and clinical research of gland disease from a range of fields as biomarkers, imaging, pathology, biology and interventional radiology etc. Readers can expect to gain new insights into diagnosis, therapeutic approaches and prognosis of gland diseases.
The journal is proud of the quality and content, which is further enhanced by a hands-on approach by its editorial team. Its international readership is reflected in the prestigious Editorial Board supported by numerous experts worldwide. It aims to advance and improve education in surgery and to diffuse knowledge on new and improved methods of teaching and practising surgery in all its branches.
The journal features original articles, case reports, cutting-edge reviews, surgical techniques and visualized surgery, thus representing a source of valuable, novel information for clinical and basic researchers alike. The entire submission and review process are managed through OJS, an electronic system to increase efficiency and ensure that submitted papers can be published within a short turnaround period.
Information for Authors
GS is a member of the International Committee of Medical Journal Editors (ICMJE) and follows the ICMJE recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journal and the Committee on Publication Ethics (COPE)'s guidelines.
Manuscripts submitted must be the original work of the author(s) and must not be published previously or under consideration for publication elsewhere.
Manuscripts Turnaround Time
- In-house review: 1-3 weeks
- External peer review: 1-3 months
- Publication Ahead of Print: within 1 month after being accepted
- Formal publication: within 1-3 months after being accepted. Original Articles are listed as priority.
GS is the Official Publication of:
The Society for Translational Medicine (STM), Hong Kong
Open Access Statement
This journal is a peer reviewed, open access journal. All content of the journal is published under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0). All articles published open access will be immediately and permanently free for all to read, download, copy and distribute as defined by the applied license.
Free access and usage
Permitted third party reuse is defined by the CC BY-NC-ND 4.0 license. This license allows users to copy and distribute the article, provided:
- this is not done for commercial purposes and further does not permit distribution of the Article if it is changed or edited in any way.
- the user gives appropriate credit (with a link to the formal publication through the relevant DOI) and provides a link to the license but not in an any way implying that the licensor is endorsing the user or the use of the work.
- no derivatives including remix, transform, or build upon the material was allowed for distribution.
The full details of the license are available at https://creativecommons.org/licenses/by-nc-nd/4.0/
For open access publishing, this journal uses an exclusive licensing agreement. Authors will transfer copyright to GS, but will have the right to share their article in the same way permitted to third parties under the relevant user license, as well as certain scholarly usage rights.
For any inquiry/special circumstance on the copyright, commercial usage or adaptation of GS articles, please contact: firstname.lastname@example.org
For reprint order, please contact: email@example.com
GS is published by AME Publishing Company.
Address: Flat/RM C 16F, Kings Wing Plaza 1, NO. 3 on Kwan Street, Shatin, NT, Hong Kong, China.
Updated on July 1, 2021